Geode Capital Management’s Biora Therapeutics, Inc. Common Stock BIOR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-15,630
| Closed | -$78.4K | – | 4603 |
|
|
2024
Q3 | $78.4K | Sell |
15,630
-3,173
| -17% | -$15.9K | ﹤0.01% | 4165 |
|
|
2024
Q2 | $124K | Sell |
18,803
-1,122
| -6% | -$7.41K | ﹤0.01% | 4073 |
|
|
2024
Q1 | $219K | Buy |
19,925
+10,621
| +114% | +$117K | ﹤0.01% | 3911 |
|
|
2023
Q4 | $126K | Buy |
9,304
+397
| +4% | +$5.36K | ﹤0.01% | 4106 |
|
|
2023
Q3 | $193K | Buy |
8,907
+826
| +10% | +$17.9K | ﹤0.01% | 3998 |
|
|
2023
Q2 | $311K | Buy |
8,081
+3,672
| +83% | +$141K | ﹤0.01% | 3839 |
|
|
2023
Q1 | $122K | Sell |
4,409
-1
| -0% | -$28 | ﹤0.01% | 4266 |
|
|
2022
Q4 | $167K | Sell |
4,410
-269
| -6% | -$10.2K | ﹤0.01% | 4197 |
|
|
2022
Q3 | $567K | Buy |
4,679
+11
| +0.2% | +$1.33K | ﹤0.01% | 3658 |
|
|
2022
Q2 | $816K | Buy |
4,668
+54
| +1% | +$9.44K | ﹤0.01% | 3514 |
|
|
2022
Q1 | $1.34M | Buy |
4,614
+238
| +5% | +$69K | ﹤0.01% | 3475 |
|
|
2021
Q4 | $2.29M | Buy |
4,376
+3,103
| +244% | +$1.62M | ﹤0.01% | 3302 |
|
|
2021
Q3 | $483K | Buy |
1,273
+490
| +63% | +$186K | ﹤0.01% | 4046 |
|
|
2021
Q2 | $698K | Sell |
783
-461
| -37% | -$411K | ﹤0.01% | 3780 |
|
|
2021
Q1 | $1.48M | Buy |
1,244
+644
| +107% | +$766K | ﹤0.01% | 3398 |
|
|
2020
Q4 | $796K | Buy |
600
+375
| +167% | +$498K | ﹤0.01% | 3436 |
|
|
2020
Q3 | $507K | Buy |
225
+106
| +89% | +$239K | ﹤0.01% | 3426 |
|
|
2020
Q2 | $268K | Buy |
+119
| New | +$268K | ﹤0.01% | 3581 |
|